Not exact matches
A new study led by scientists at Beth Israel Deaconess Medical Center (BIDMC) shows that an HIV - 1
vaccine regimen, involving a viral
vector boosted with a purified envelope protein, provided complete protection in half of the vaccinated non-human primates (NHPs) against a series of six repeated challenges with simian immunodeficiency virus (SIV), a virus similar to HIV that infects NHPs.
RV 172: A Phase I / II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV - 1 DNA Plasmid
Vaccine, VRC - HIVDNA016 -00-VP,
Boosted by a Multiclade HIV - 1 Recombinant ADENOVIRUS - 5
Vector Vaccine, VRC - HIVADV014 -00-VP in HIV Uninfected Adu
She added that «this is one component of our heterologous
vaccine strategy, which will encompass multiple inserts and
vectors in a prime -
boost format.»